Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.04
Tweet
Share
E-mailGet Alerts CPIX Hot Sheet
Join SI Premium – FREE
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $7.4 million, versus $8.9 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Manhattan Associates, Inc. (MANH) Tops Q1 EPS by 16c; offers guidance
- Canadian National Railway (CNI) Tops Q1 EPS by 1c, provides outlook
- South Atlantic Bancshares, Inc. (SABK) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
